title: [Revolution in the treatment of hepatitis C -- how to adopt the guidelines afterwards?].
authors.affiliation: Geschäftsstelle der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten, Berlin.
authors.forename: P
authors.initials: P
authors.lastname: Lynen Jansen
authors.affiliation: AWMF Institut für Medizinisches Wissensmanagement (IMWI), Philipps-Universität Marburg.
authors.forename: I
authors.initials: I
authors.lastname: Kopp
authors.affiliation: AWMF Institut für Medizinisches Wissensmanagement (IMWI), Philipps-Universität Marburg.
authors.forename: M
authors.initials: M
authors.lastname: Nothacker
authors.affiliation: Medizinische Klinik 1, Klinikum der Goethe-Universität, Frankfurt a. M.
authors.forename: S
authors.initials: S
authors.lastname: Zeuzem
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D000998:Antiviral Agents / Q000008:administration & dosage* / Q000592:standards*; D005858:Germany; D019983:Guideline Adherence; D006526:Hepatitis C / Q000188:drug therapy* / Q000517:prevention & control*; D006801:Humans; D017410:Practice Guidelines as Topic; D014773:Virology / Q000592:standards* / Q000639:trends*
chemical_list: D000911:Antibodies, Monoclonal; D000998:Antiviral Agents